Similar articles for PMID: 30361178

Year	Number of Results
2009	2
2011	2
2012	2
2013	5
2014	3
2015	20
2016	23
2017	36
2018	16
2019	5
2020	3
2023	1
2024	0

1

[Update from France Macula Federation: Treatment of Wet AMD].

Tick S, Cornut PL, De Bats F, Wolf B, Souied EH, Cohen SY. Tick S, et al. J Fr Ophtalmol. 2018 Nov;41(9):862-867. doi: 10.1016/j.jfo.2018.06.002. Epub 2018 Oct 22. J Fr Ophtalmol. 2018. PMID: 30361178 French.

2

[Update from France Macula Federation: Diagnosis of wet AMD].

Wolff B, De Bats F, Tick S, Cornut PL, Souied É, Cohen SY. Wolff B, et al. J Fr Ophtalmol. 2018 Nov;41(9):857-861. doi: 10.1016/j.jfo.2018.05.004. Epub 2018 Oct 19. J Fr Ophtalmol. 2018. PMID: 30348597 French.

3

[Management of wet AMD in France in 2015].

Zerbib J, Bourhis A, Cornut PL, De Bats F, Grenet T, Gualino V, Halfon J, Massé H, Srour M, Streho M, Tick S, Wolff B, San Nicolas N. Zerbib J, et al. J Fr Ophtalmol. 2017 Nov;40(9):723-730. doi: 10.1016/j.jfo.2017.05.009. Epub 2017 Oct 18. J Fr Ophtalmol. 2017. PMID: 29055730 French.

4

Vitreomacular Interface after Anti-Vascular Endothelial Growth Factor Injections in Neovascular Age-Related Macular Degeneration.

Veloso CE, Kanadani TM, Pereira FB, Nehemy MB. Veloso CE, et al. Ophthalmology. 2015 Aug;122(8):1569-72. doi: 10.1016/j.ophtha.2015.04.028. Epub 2015 May 30. Ophthalmology. 2015. PMID: 26038338

5

Switch to aflibercept or ranibizumab after initial treatment with bevacizumab in eyes with neovascular AMD.

Waizel M, Todorova MG, Masyk M, Wolf K, Rickmann A, Helaiwa K, Blanke BR, Szurman P. Waizel M, et al. BMC Ophthalmol. 2017 May 23;17(1):79. doi: 10.1186/s12886-017-0471-x. BMC Ophthalmol. 2017. PMID: 28535756 Free PMC article.

6

Two-year functional and anatomical results after converting treatment resistant eyes with exudative age-related macular degeneration to aflibercept in accordance with a treat and extend protocol.

Jørstad ØK, Faber RT, Moe MC. Jørstad ØK, et al. Acta Ophthalmol. 2017 Aug;95(5):460-463. doi: 10.1111/aos.13480. Epub 2017 May 29. Acta Ophthalmol. 2017. PMID: 28556485 Free article.

7

SAVE-AMD: Safety of VEGF Inhibitors in Age-Related Macular Degeneration.

Enseleit F, Michels S, Sudano I, Stahel M, Zweifel S, Schlager O, Becker M, Winnik S, Nägele M, Flammer AJ, Neidhart M, Graf N, Matter CM, Seifert B, Lüscher TF, Ruschitzka F. Enseleit F, et al. Ophthalmologica. 2017;238(4):205-216. doi: 10.1159/000478665. Epub 2017 Sep 2. Ophthalmologica. 2017. PMID: 28866675 Free PMC article. Clinical Trial.

8

Intravitreal anti-VEGF injections for treating wet age-related macular degeneration: a systematic review and meta-analysis.

Ba J, Peng RS, Xu D, Li YH, Shi H, Wang Q, Yu J. Ba J, et al. Drug Des Devel Ther. 2015 Sep 28;9:5397-405. doi: 10.2147/DDDT.S86269. eCollection 2015. Drug Des Devel Ther. 2015. PMID: 26451092 Free PMC article. Review.

9

Change of retinal pigment epithelial atrophy after anti-vascular endothelial growth factor treatment in exudative age-related macular degeneration.

Kim M, Kim ES, Seo KH, Yu SY, Kwak HW. Kim M, et al. Indian J Ophthalmol. 2016 Jun;64(6):427-33. doi: 10.4103/0301-4738.187659. Indian J Ophthalmol. 2016. PMID: 27488150 Free PMC article.

10

SYSTEMIC PHARMACOKINETICS AND PHARMACODYNAMICS OF INTRAVITREAL AFLIBERCEPT, BEVACIZUMAB, AND RANIBIZUMAB.

Avery RL, Castellarin AA, Steinle NC, Dhoot DS, Pieramici DJ, See R, Couvillion S, Nasir MA, Rabena MD, Maia M, Van Everen S, Le K, Hanley WD. Avery RL, et al. Retina. 2017 Oct;37(10):1847-1858. doi: 10.1097/IAE.0000000000001493. Retina. 2017. PMID: 28106709 Free PMC article. Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

101 results

Results by year